**Author details**

Jonason Yang, Nunki Hassan, Sheng Xiang Franklin Chen, Jayvee Datuin and Jenny Y. Wang\* Cancer and Stem Cell Biology Group, Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, Australia

\*Address all correspondence to: jenny.wang@unsw.edu.au

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**105**

*Self-Renewal Pathways in Acute Myeloid Leukemia Stem Cells*

[9] Dick JE. Stem cell concepts renew cancer research. Blood. 2008;112(13):4793-807.

1997;3(7):730-7.

1995;85(8):2154-61.

2003;17(24):3029-35.

[10] Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med.

[11] Turhan A, Lemoine F, Debert C, Bonnet M, Baillou C, Picard F, et al. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia. Blood.

[12] Cozzio A, Passegue E, Ayton PM, Karsunky H, Cleary ML, Weissman IL. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes & development.

[13] Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9. Nature. 2006;442(7104):818-22.

[14] Chan WI, Huntly BJ. Leukemia stem cells in acute myeloid leukemia. Semin

Oncol. 2008;35(4):326-35.

[15] Saito Y, Uchida N, Tanaka S, Suzuki N, Tomizawa-Murasawa M, Sone A, et al. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Nature biotechnology. 2010;28(3):275-80.

[16] Murry DJ, Blaney SM. Clinical Pharmacology of Encapsulated

Sustained-Release Cytarabine. Annals of Pharmacotherapy. 2000;34(10):1173-8.

[17] Murphy T, Yee KWL. Cytarabine and daunorubicin for the treatment

*DOI: http://dx.doi.org/10.5772/intechopen.94379*

[2] O'Brien E, Prideaux S, Chevassut T. The Epigenetic Landscape of Acute Myeloid Leukemia. Advances in hematology. 2014;2014:103175.

Berdel WE, Krug U. Prognostic factors for acute myeloid leukaemia in adults- biological significance and clinical use. Br J Haematol. 2014;165(1):17-38.

[1] Li S, Mason CE, Melnick A. Genetic and epigenetic heterogeneity in acute myeloid leukemia. Current Opinion in Genetics & Development.

[3] Liersch R, Muller-Tidow C,

[4] Ishikawa F, Yoshida S, Saito Y, Hijikata A, Kitamura H, Tanaka S, et al. Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region. Nat Biotechnol.

[5] Wang Y, Krivtsov AV, Sinha AU, North TE, Goessling W, Feng Z, et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science.

2007;25(11):1315-21.

2010;327(5973):1650-3.

2020;38(2):263-78.

[6] Salik B, Yi H, Hassan N,

[7] Yamamoto R, Morita Y,

Cell. 2013;154(5):1112-26.

Physiol. 2010;222(1):17-22.

[8] Eliasson P, Jonsson JI. The

hematopoietic stem cell niche: low in oxygen but a nice place to be. J Cell

Santiappillai N, Vick B, Connerty P, et al. Targeting RSPO3-LGR4 Signaling for Leukemia Stem Cell Eradication in Acute Myeloid Leukemia. Cancer cell.

Ooehara J, Hamanaka S, Onodera M, Rudolph KL, et al. Clonal analysis unveils self-renewing lineagerestricted progenitors generated directly from hematopoietic stem cells.

2016;36:100-6.

**References**

*Self-Renewal Pathways in Acute Myeloid Leukemia Stem Cells DOI: http://dx.doi.org/10.5772/intechopen.94379*
